Test Price
2,800 AEDโ Home Collection Available
VPS54-Related Amyotrophic Lateral Sclerosis (ALS) Genetic Test in UAE
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 15189 certified Next-Generation Sequencing (NGS) processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM across Dubai and the Northern Emirates.
Clinical Guidance: Telephonic post-test clinical guidance in result interpretation by DHA-licensed genetics specialists.
Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The VPS54-Related Amyotrophic Lateral Sclerosis (ALS) Genetic Test analyzes the entire coding region and splice sites of the VPS54 gene using Next-Generation Sequencing (NGS) to detect pathogenic variants linked to a rare autosomal dominant form of motor neuron disease. This targeted genetic analysis is essential for at-risk individuals, guiding early surveillance, family planning discussions, and personalized neurological care. The test is performed exclusively on whole blood specimens collected under stringent quality-controlled conditions.
| Feature | Our Test (VPS54 NGS) | Standard ALS Panel |
|---|---|---|
| Technology | Next-Generation Sequencing (NGS) | Limited PCR / MLPA |
| Gene Coverage | Full VPS54 gene (all exons, splice sites) | Select anomalies in multiple ALS genes |
| Turnaround Time | 3โ4 Weeks | 4โ6 Weeks |
| Analytical Sensitivity | >99.9% (ISO 15189) | Variable ~98% |
Physician Insight & Safety Protocols
โAs a Consultant Medical Genetics specialist licensed by the Dubai Health Authority, I emphasize that a positive VPS54 mutation alone is not a clinical diagnosis of ALS; it requires correlation with electromyography, neurological examination, and comprehensive family history. A negative result does not exclude other genetic or sporadic forms of motor neuron disease. I strongly advise all patients to undergo pre-test genetic counseling to fully understand the implications for themselves and their families before proceeding with testing.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Notice: Medication Continuation
Critical Medication Warning
Do not discontinue any prescribed medication (e.g., riluzole, edaravone) without consulting your treating neurologist. Genetic test results do not replace ongoing clinical management or prescribed therapeutic regimens. Always adhere to your physician's guidance regarding medication adjustments.
Exclusion Criteria & Clinical Red Flags
Patient Exclusion Criteria
- Minors under 18 years of age without legally authorized guardian consent, in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Acute respiratory distress or severe dysphagia โ seek emergency medical care immediately before sample collection.
- Recent blood transfusion (within 2 weeks) may affect germline DNA analysis; please inform the phlebotomist prior to collection.
- Results are not intended for asymptomatic minors unless clinically indicated and accompanied by formal genetic counseling.
Patient FAQ & Clinical Guidance
1. What does the VPS54 gene test detect, and why is it important?
This NGS-based test identifies heritable pathogenic variants in the VPS54 gene that cause a rare autosomal dominant form of amyotrophic lateral sclerosis. Early detection enables at-risk individuals to pursue informed family planning, initiate proactive neurological surveillance, and access emerging therapeutic options under specialist guidance.
2. How is the test performed, and what sample is required?
A standard peripheral whole blood sample is collected by a DHA-licensed phlebotomist at your home via our ISO-certified cold-chain mobile phlebotomy service (available daily 8 AMโ11 PM). DNA is extracted from the white blood cells and sequenced using NGS technology to analyze the complete VPS54 coding region.
3. What do abnormal results mean for my family members?
A positive pathogenic mutation indicates a 50% chance of passing the ALS risk variant to each biological child. Genetic counseling is mandatory to discuss predictive testing options for at-risk relatives and to address psychological, ethical, and family planning considerations.
4. How long does it take to receive results?
The standard turnaround time for this comprehensive NGS analysis is 3โ4 weeks from sample receipt. Results are delivered electronically via a secure patient portal, followed by a telephonic consultation with a DHA-licensed genetics specialist to explain the findings.
UAE Regulatory & Data Privacy Adherence
This service strictly complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) governing the confidentiality and security of genetic data, and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All testing is performed under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) accredited laboratory protocols with full adherence to Federal Decree-Law No. 4 of 2016 on Medical Liability regarding patient consent and clinical safety.
Clinical & Logistical Metadata
| Test Name | VPS54-Related Amyotrophic Lateral Sclerosis (ALS) Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Whole Blood (Peripheral) โ VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection Available Daily 8 AMโ11 PM |
| Methodology Used | Next-Generation Sequencing (NGS) โ Full Gene Coding Region & Splice Site Analysis |
| ICD-10-CM Code | G12.21 |
| LOINC Code | 88215-6 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians